J. M. Venstrom, G. Pittari, T. A. Gooley, J. H. Chewning, S. Spellman et al., HLA-CDependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1, New England Journal of Medicine, vol.367, issue.9, pp.805-821, 2012.

P. Parham and A. Moffett, Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution, Nature reviews Immunology, vol.13, issue.2, pp.133-177, 2013.

A. A. Bashirova, R. Thomas, and M. Carrington, HLA/KIR restraint of HIV: surviving the fittest, Annu Rev Immunol, vol.29, pp.295-317, 2011.

M. Altfeld, L. Fadda, D. Frleta, and N. Bhardwaj, DCs and NK cells: critical effectors in the immune response to HIV-1, Nature reviews Immunology, vol.11, issue.3, pp.176-86, 2011.

C. A. Biron, Activation and function of natural killer cell responses during viral infections, Curr Opin Immunol, vol.9, issue.1, pp.24-34, 1997.

P. Parham, Influence of KIR diversity on human immunity, Adv Exp Med Biol, vol.560, pp.47-50, 2005.

M. Colonna, A. Moretta, F. Vely, and E. Vivier, A high-resolution view of NK-cell receptors: structure and function, Immunol Today, vol.21, issue.9, pp.428-459, 2000.

L. Moretta, C. Bottino, D. Pende, R. Castriconi, M. C. Mingari et al., Surface NK receptors and their ligands on tumor cells, Semin Immunol, vol.18, issue.3, pp.151-159, 2006.

G. Kaur, J. Trowsdale, and L. Fugger, Natural killer cells and their receptors in multiple sclerosis, Brain, vol.136, pp.2657-76, 2013.

I. Jelcic, K. C. Hsu, K. Kakalacheva, P. Breiden, B. Dupont et al., Killer immunoglobulinlike receptor locus polymorphisms in multiple sclerosis, Mult Scler, vol.18, issue.7, pp.951-959, 2012.

A. Bettencourt, A. M. Silva, C. Carvalho, B. Leal, E. Santos et al., The role of KIR2DS1 in multiple sclerosis-KIR in Portuguese MS patients, J Neuroimmunol, vol.269, issue.1-2, pp.52-57, 2014.

C. Fusco, F. R. Guerini, G. Nocera, G. Ventrella, D. Caputo et al., KIRs and their HLA ligands in remitting-relapsing multiple sclerosis, J Neuroimmunol, vol.229, issue.1-2, pp.232-239, 2010.

A. R. Lorentzen, T. H. Karlsen, M. Olsson, C. Smestad, I. L. Mero et al., Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis, Ann Neurol, vol.65, issue.6, pp.658-66, 2009.

M. T. Wallin, W. J. Culpepper, P. Coffman, S. Pulaski, H. Maloni et al., The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service, Brain, vol.135, pp.1778-85, 2012.

A. Langer-gould, S. M. Brara, B. E. Beaber, and J. L. Zhang, Incidence of multiple sclerosis in multiple racial and ethnic groups, Neurology, vol.80, pp.1734-1743, 2013.

B. A. Cree, O. Khan, D. Bourdette, D. S. Goodin, J. A. Cohen et al., Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis, Neurology, vol.63, issue.11, pp.2039-2084, 2004.

B. A. Cree, D. E. Reich, O. Khan, D. Jager, P. L. Nakashima et al., Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA, Arch Neurol, vol.66, issue.2, pp.226-259, 2009.

J. R. Oksenberg, L. F. Barcellos, B. A. Cree, S. E. Baranzini, T. L. Bugawan et al., Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans, Am J Hum Genet, vol.74, issue.1, pp.160-167, 2004.

S. J. Caillier, F. Briggs, B. A. Cree, S. E. Baranzini, M. Fernandez-vina et al., Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis, J Immunol, vol.181, issue.8, pp.5473-80, 2008.

J. A. Hollenbach, I. Nocedal, M. B. Ladner, R. M. Single, and E. A. Trachtenberg, Killer cell immunoglobulinlike receptor (KIR) gene content variation in the HGDP-CEPH populations, Immunogenetics, vol.64, issue.10, pp.719-756, 2012.

J. A. Hollenbach and J. R. Oksenberg, The immunogenetics of multiple sclerosis: A comprehensive review, J Autoimmun, 2015.

M. J. Pando, C. M. Gardiner, M. Gleimer, K. L. Mcqueen, and P. Parham, The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1, J Immunol, vol.171, issue.12, pp.6640-6649, 2003.

P. J. Norman, J. A. Hollenbach, N. Nemat-gorgani, L. A. Guethlein, H. G. Hilton et al., Coevolution of Human Leukocyte Antigen (HLA) Class I Ligands with Killer-Cell ImmunoglobulinLike Receptors (KIR) in a Genetically Diverse Population of Sub-Saharan Africans, PLoS genetics, vol.9, issue.10, 2013.

M. A. Fernandez-vina, J. A. Hollenbach, K. E. Lyke, M. B. Sztein, M. Maiers et al., Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations, Philosophical transactions of the Royal Society of London, vol.367, pp.820-829, 1590.

W. I. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. P. Hartung et al., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, Ann Neurol, vol.50, issue.1, pp.121-128, 2001.

C. H. Polman, S. C. Reingold, B. Banwell, M. Clanet, J. A. Cohen et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol, vol.69, issue.2, pp.292-302, 2011.

N. Isobe, L. Madireddy, P. Khankhanian, T. Matsushita, S. J. Caillier et al., An ImmunoChip study of multiple sclerosis risk in African Americans, Brain, vol.138, pp.1518-1548, 2015.

R. Development-core and . Team, R: A language and environment for statistical computing, 2008.

T. Aragon, epitools: Epidemiology Tools. R package version 0.5-7, 2012.

J. A. Hollenbach, S. J. Mack, G. Thomson, and P. A. Gourraud, Analytical methods for disease association studies with immunogenetic data, Methods Mol Biol, vol.882, pp.245-66, 2012.

D. J. Schaid, C. M. Rowland, D. E. Tines, R. M. Jacobson, and G. A. Poland, Score tests for association between traits and haplotypes when linkage phase is ambiguous, American Journal of Human Genetics, vol.70, pp.425-459, 2002.

J. Sinnwell, D. Schaid, and . Haplo, stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous

. Hollenbach, , p.11